REGENERATIVE SOLUTIONS FOR SPORTS MEDICINE

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam ultrices vitae lectus at tincidunt. Quisque euismod ultrices vestibulum. Nullam eu tortor quis quam cursus consectetur iaculis nec nibh. Suspendisse commodo tincidunt eros, ut accumsan mauris pretium ac. Nunc a nunc pellentesque, fermentum urna ac, accumsan mi. Aliquam non ipsum dolor. Donec sit amet purus non turpis iaculis eleifend. Nam in congue enim. Integer at consectetur urna. Aliquam felis tortor, aliquam ut tortor at, iaculis mollis ex. Aenean a tellus ut velit mattis lobortis. Mauris quis nulla sed lectus ultrices vehicula ut vitae tortor. Nunc neque est, convallis nec ligula non, egestas vestibulum nisl. Praesent at viverra mi. Vestibulum orci felis, congue vitae tincidunt ut, auctor non nisi. Quisque dictum porttitor sem, et mollis neque auctor et.

Etiam sit amet leo sollicitudin, sagittis quam quis, auctor ipsum. Nam facilisis, mi et malesuada aliquam, tellus nisi efficitur arcu, tincidunt pellentesque enim risus nec eros. Donec sollicitudin venenatis tempus. Quisque lacus lacus, cursus at accumsan ac, suscipit quis orci. Donec mollis justo sit amet lacus suscipit interdum. Nam et nunc neque. Nunc lorem dui, feugiat vitae tincidunt a, sagittis sit amet risus. Sed tristique nibh odio, a porttitor ex euismod at. Etiam consequat pretium leo scelerisque aliquam. Interdum et malesuada fames ac ante ipsum primis in faucibus. Pellentesque congue libero quis est mollis ullamcorper. Nam eros sem, sagittis at dignissim sit amet, congue in leo. Etiam efficitur est imperdiet metus semper, id vehicula mauris malesuada.

Feb 12-16 – San Francisco, CA - Booth #126

American Academy of Orthopaedic Surgeons (AAOS)

Learn More
Tetrous

© Tetrous, Inc. All rights reserved.

Bradley E. Patt, PhD

Dr. Patt is cofounder chairman of Tetrous.

Brad has over 40 years experience as an entrepreneur and executive manager. He has led several enterprises from start-up phase through rapid growth and merger and acquisitions.

Brad founded several high tech ventures since 1997. He is currently co-founder chairman and CEO of TheraCell and DermOQ. Previously he was co-founder, CEO and Chairman of Gamma Medica, Inc. Brad built Gamma to market leadership position in pre­clinical CT, PET, SPECT imaging and is inventor and developer of Molecular Breast Imaging for detecting otherwise occult breast cancer in dense­breasted women.

Brad is currently co­founder and Chairman of DermOQ, Inc., an oxygen skin care company; EVO Worldwide, Inc. and spin off Smart Breast Corp., medical diagnostic imaging systems companies; and Hyvida Brands, a functional beverage startup. He is a director of High Beauty a cannabis cosmetic company. Brad also founded and is a Director of Thrive Outside the Box, a nonprofit organization that identifies and develops areas of talent in individuals on the autistic spectrum.

Brad is an internationally recognized authority in the field of medical imaging with over one hundred scientific papers and presentations, several book chapters, and over 20 patents. He has been an invited speaker at several international conferences. He has held elected positions on the IEEE Nuclear Medicine Instrumentation Steering Committee (NMISC) and the IEEE Radiation Instrumentation Steering Committee (RISC), and was appointed to the Program Committee of the SPIE Medical applications of Penetrating Radiation, acting as Chairman of the Penetrating Radiation Work Group for 2003 and 2004. Dr. Patt is a consultant to the National Institutes of Health and the recipient of over $15 million dollars of grant awards as Principal Investigator from the National Institutes of Health, The United States Department of Energy and NASA.

Bradley E. Patt, PhD

Dr. Patt is cofounder chairman of Tetrous. Brad has over 40 years experience as an entrepreneur and executive manager. He has led several enterprises from start-up phase through rapid growth and merger and acquisitions. Brad founded several high tech ventures since 1997. He is currently co-founder chairman and CEO of TheraCell and DermOQ. Previously he was co-founder, CEO and Chairman of Gamma Medica, Inc. Brad built Gamma to market leadership position in pre­clinical CT, PET, SPECT imaging and is inventor and developer of Molecular Breast Imaging for detecting otherwise occult breast cancer in dense­breasted women. Brad is currently co­founder and Chairman of DermOQ, Inc., an oxygen skin care company; EVO Worldwide, Inc. and spin off Smart Breast Corp., medical diagnostic imaging systems companies; and Hyvida Brands, a functional beverage startup. He is a director of High Beauty a cannabis cosmetic company. Brad also founded and is a Director of Thrive Outside the Box, a nonprofit organization that identifies and develops areas of talent in individuals on the autistic spectrum. Brad is an internationally recognized authority in the field of medical imaging with over one hundred scientific papers and presentations, several book chapters, and over 20 patents. He has been an invited speaker at several international conferences. He has held elected positions on the IEEE Nuclear Medicine Instrumentation Steering Committee (NMISC) and the IEEE Radiation Instrumentation Steering Committee (RISC), and was appointed to the Program Committee of the SPIE Medical applications of Penetrating Radiation, acting as Chairman of the Penetrating Radiation Work Group for 2003 and 2004. Dr. Patt is a consultant to the National Institutes of Health and the recipient of over $15 million dollars of grant awards as Principal Investigator from the National Institutes of Health, The United States Department of Energy and NASA.